New insider Maggio Nicole claimed ownership of 15,059 shares (SEC Form 3)
$OPCH
Medical/Nursing Services
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/01/2024 |
3. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 15,059(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Employee Stock Option (right to buy) | (2) | 02/22/2033 | Common Stock | 5,500 | $28.86 | D | |
| Employee Stock Option (right to buy) | (3) | 02/17/2032 | Common Stock | 3,852 | $23.96 | D | |
| Employee Stock Option (right to buy) | (4) | 10/21/2031 | Common Stock | 3,366 | $25.75 | D | |
| Explanation of Responses: |
| 1. Includes (i) 3,738 restricted stock units that vest as to one-third of the underlying shares of Common Stock on each of February 20, 2025, February 20, 2026 and February 20, 2027, (ii) 2,247 restricted stock units that vest as to one-third of the underlying shares of Common Stock on each of February 22, 2025, February 22, 2026 and February 22, 2027, (iii) 992 restricted stock units that vest as to 50% of the underlying shares of Common Stock each of February 17, 2025 and February 17, 2026, (iv) 1,166 restricted stock units that vest on October 21, 2024, and (v) 712 restricted stock units that vest on February 23, 2025. |
| 2. 1,375 stock options vested on February 22, 2024; 1,375 stock options vest on February 22, 2025, February 22, 2026 and February 22, 2027. |
| 3. 963 stock options vested on February 17, 2023 and February 17, 2024; 963 stock options vest on February 17, 2025 and February 17, 2026. |
| 4. Stock option vests in full on October 21, 2024. |
| /s/ Sarah Kim, attorney-in-fact for Ms. Maggio | 08/09/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||